RESULTS OF CRANIOSPINAL IRRADIATION AFTER SURGERY IN MEDULLOBLASTOMA AT CHO RAY HOSPITAL

Hoàng Hiệp Trần, Trung Kiên Doãn

Main Article Content

Abstract

Purpose: Evaluating the results of of craniospinal irradiation after surgery in medulloblastoma at Cho Ray hospital. Materials and methods: Retrospective study of 31 surgically treated medulloblastoma patients who received craniospinal irradiation at Radiation department – Cho Ray Cancer Center from January 1, 2018 to December 31, 2023 (6 years). Results: The male/female ratio is 1.38, children ≤ 16 years old account for 67.7%. The most common tumor location is in the cerebellum (accounting for 65%), the fourth ventricle (26%). The average tumor size is 4.7 ± 0.9 cm (2.5 – 7 cm). 61% had gross total resection, 29% had near total resection, and 10% had partial resection. Median PFS was 53.4 ± 5.7 months, 1-year PFS was 83.4%, 2-year was 70.8%, 3-year was 66.1%, 4-year was 60.6%, and 5-year was 60 .6%. Median OS was 58 ± 5.3 months, 1-year OS was 90.1%, 2-year was 74.3%, 3-year was 69.3%, 4-year was 69.3% and 5-year was 69.3%. The difference between gross total resection and near total resection is not statistically significant in both PFS and OS. The difference is statistically significant when compared to partial resection (p=0.001). Conclusion: Combining surgery and post-operative craniospinal irradiation brings very positive results in the treatment of medulloblastoma.

Article Details

References

1. Liu Y. et al. (2005). Radiation treatment for medulloblastoma: a review of 64 cases at a single institute. Japanese journal of clinical oncology. 35(3): p. 111-115.
2. Khanna V. et al. (2017) Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013. Journal of neuro-oncology, 135: p. 433-441.
3. Phạm Thanh Tuân, Kiều Đình Hùng, Phạm Cẩm Phương. (2023). Đặc điểm lâm sàng, kết quả điều trị phẫu thuật và xạ trị gia tốc u nguyên bào tủy tại bệnh viện Việt Đức. Tạp chí y học Việt Nam, Tập 528, tháng 7, số 2: p. 190-195.
4. Nalita N. et al. (2018). Survival and prognostic factors in pediatric patients with medulloblastoma in Southern Thailand. Journal of Pediatric Neurosciences, 13(2): p. 150-157.
5. Seidel C. et al. (2021). Radiotherapy in medulloblastoma—evolution of treatment, current concepts and future perspectives. Cancers, 13(23): p. 5945.
6. Tandian D. et al. (2021). Risk factors associated with post-therapeutic outcome for medulloblastoma: An experience from Indonesia. Asian Journal of Neurosurgery, 16(03): p. 494-499.
7. Thompson E.M. et al. (2016). Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. The lancet oncology, 17(4): p. 484-495.